Zogenix
Latest round
- Series C
Last raised
- Dec 2009
Total raised
- $150M
Investors
- 9
About Zogenix
Based in California, US, and founded in 2006, Zogenix Inc. operates as a biotechnology company that develops products used for the treatment of patients with central nervous system disorders and pain. They provide ZX008 (low-dose fenfluramine) for the treatment of Dravet syndrome and ZX008 (low-dose fenfluramine) for the treatment of Lennox-Gastaut syndrome (LGS).
Who invested in Zogenix
9 investors across 5 rounds
See all investors in Zogenix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Zogenix
Who invested in Zogenix?
Zogenix has 9 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zogenix raised?
Zogenix has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Zogenix last raise money?
Zogenix's most recent round on record is a Series C, in Dec 2009.
What does Zogenix do?
Based in California, US, and founded in 2006, Zogenix Inc.
Where is Zogenix headquartered?
Zogenix is headquartered in Emeryville, US.
Which VCs invest in companies like Zogenix?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Zogenix's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Zogenix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.